HOOK3-RET: A novel type of RET/PTC rearrangement in papillary thyroid carcinoma

Endocrine-Related Cancer

Volumn 14, Issue 2, 2007, Pages 445-452

  Ciampi, Raffaele ^a,e   Giordano, Thomas J ^b   Wikenheiser Brokamp, Kathryn ^a   Koenig, Ronald J ^b   Nikiforov, Yuri E ^a,c,d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN ANTIBODY; PROTEIN RET; PROTEIN TYROSINE KINASE; RET ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL STRAIN 3T3; CONTROLLED STUDY; DNA MICROARRAY; EXON; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE FUSION; GENE IDENTIFICATION; GENETIC CODE; HOOK3 GENE; HUMAN; HUMAN TISSUE; KARYOTYPE; MICROARRAY ANALYSIS; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLARY CARCINOMA; PROTEIN DOMAIN; PROTO ONCOGENE; THYROID CARCINOMA; WESTERN BLOTTING;

ANIMALS; CARCINOMA, PAPILLARY; FEMALE; GENE EXPRESSION; HUMANS; MICE; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; NIH 3T3 CELLS; ONCOGENE FUSION; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS C-RET; RECOMBINATION, GENETIC; THYROID NEOPLASMS;

EID: 34547819754     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-07-0039     Document Type: Article

References (38)

1. Airaksinen MS, Titievsky A & Saarma M 1999 GDNF family neurotrophic factor signaling: four masters, one servant? Molecular and Cellular Neurosciences 13 313-325.
2. Argani P, Zakowski MF, Klimstra DS, Rosai J & Ladanyi M 1998 Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases. Modern Pathology 11 65-71.
3. Bongarzone I, Monzini N, Borrello MG, Carcano C, Ferraresi G, Arighi E, Mondellini P, Della Porta G & Pierotti MA 1993 Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A. Molecular and Cellular Biology 13 358-366.
4. Bongarzone I, Butti MG, Coronelli S, Borrello MG, Santoro M, Mondellini P, Pilotti S, Fusco A, Della Porta G & Pierotti MA 1994 Frequent activation of ret proto-oncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Research 54 2979-2985.
5. Ciampi R & Nikiforov YE 2005 Alterations of the BRAF gene in thyroid tumors. Endocrine Pathology 16 163-172.
6. Ciampi R, Knauf JA, Kerler R, Gandhi M, Zhu Z, Nikiforova MN, Rabes HM, Fagin JA & Nikiforov YE 2005 Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. Journal of Clinical Investigation 115 94-101.
7. Corvi R, Berger N, Balczon R & Romeo G 2000 RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma. Oncogene 19 4236-4242.
8. De Micco C 2003 Ras mutations in follicular variant of papillary thyroid carcinoma. American Journal of Clinical Pathology 120 803-804.
9. Frattini M, Ferrario C, Bressan P, Balestra D, De Cecco L, Mondellini P, Bongarzone I, Collini P, Gariboldi M, Pilotti S et al. 2004 Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer. Oncogene 23 7436-7440.
10. Fugazzola L, Pierotti MA, Vigano E, Pacini F, Vorontsova TV & Bongarzone I 1996 Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer. Oncogene 13 1093-1097.
11. Fusco A, Grieco M, Santoro M, Berlingieri MT, Pilotti S, Pierotti MA, Della Porta G & Vecchio G 1987 A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature 328 170-172.
12. Giordano TJ, Kuick R, Thomas DG, Misek DE, Vinco M, Sanders D, Zhu Z, Ciampi R, Roh M, Shedden K et al. 2005 Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene 24 6646-6656.
13. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A & Vecchio G 1990 PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60 557-563.
14. Hundahl SA, Cady B, Cunningham MP, Mazzaferri E, McKee RF, Rosai J, Shah JP, Fremgen AM, Stewart AK 6 Holzer S 2000 Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. US and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer 89 202-217.
15. Ishizaka Y, Ushijima T, Sugimura T & Nagao M 1990 cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line. Biochemical and Biophysical Research Communications 168 402-408.
16. Jhiang SM 2000 The RET proto-oncogene in human cancers. Oncogene 19 5590-5597.
17. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE & Fagin JA 2003 High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Research 63 1454-1457.
18. Klugbauer S & Rabes HM 1999 The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Oncogene 18 4388-4393.
19. Klugbauer S, Demidchik EP, Lengfelder E & Rabes HM 1998 Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5. Cancer Research 58 198-203.
20. Klugbauer S, Jauch A, Lengfelder E, Demidchik E & Rabes HM 2000 A novel type of RET rearrangement (PTC8) in childhood papillary thyroid carcinomas and characterization of the involved gene (RFG8). Cancer Research 60 7028-7032.
21. Knauf JA, Kuroda H, Basu S & Fagin JA 2003 RET/PTC-induced dedifferentiation of thyroid cells is mediated through Y1062 signaling through SHC-RAS-MAP kinase. Oncogene 22 4406-4412.
22. Kramer H & Phistry M 1996 Mutations in the Drosophila hook gene inhibit endocytosis of the boss transmembrane ligand into multivesicular bodies. Journal of Cell Biology 133 1205-1215.
23. Kunzli BM, Berberat PO, Zhu ZW, Martignoni M, Kleeff J, Tempia-Caliera AA, Fukuda M, Zimmermann A, Friess H & Buchler MW 2002 Influences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinoma. Cancer 94 228-239.
24. Minoletti F, Butti MG, Coronelli S, Miozzo M, Sozzi G, Pilotti S, Tunnacliffe A, Pierotti MA & Bongarzone I 1994 The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2. Genes Chromosomes Cancer 11 51-57.
25. Nakata T, Kitamura Y, Shimizu K, Tanaka S, Fujimori M, Yokoyama S, Ito K & Emi M 1999 Fusion of a novel gene, ELKS, to RET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma. Genes Chromosomes Cancer 25 97-103.
26. Pierotti MA, Santoro M, Jenkins RB, Sozzi G, Bongarzone I, Grieco M, Monzini N, Miozzo M, Herrmann MA, Fusco A et al. 1992 Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. PNAS 89 1616-1620.
27. Saenko V, Rogounovitch T, Shimizu-Yoshida Y, Abrosimov A, Lushnikov E, Roumiantsev P, Matsumoto N, Nakashima M, Meirmanov S, Ohtsuru A et al. 2003 Novel tumorigenic rearrangement, Delta RFP/RET, in a papillary thyroid carcinoma from externally irradiated patient. Mutation Research 527 81-90.
28. Salassidis K, Bruch J, Zitzelsberger H, Lengfelder E, Kellerer AM & Bauchinger M 2000 Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma. Cancer Research 60 2786-2789.
29. Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G & Fusco A 1994 Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 9 509-516.
30. Sevrioukov EA, He JP, Moghrabi N, Sunio A & Kramer H 1999 A role for the deep orange and carnation eye color genes in lysosomal delivery in Drosophila. Molecular Cell 4 479-486.
31. Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Maximo V, Botelho T, Seruca R & Sobrinho-Simoes M 2003 BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22 4578-4580.
32. Takahashi M 1988 Structure and expression of the ret transforming gene. IARC Scientific Publications 189-197.
33. Takahashi M, Ritz J & Cooper GM 1985 Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42 581-588.
34. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R et al. 2005 Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310 644-648.
35. Tong Q, Xing S & Jhiang SM 1997 Leucine zipper-mediated dimerization is essential for the PTC1 oncogenic activity. Journal of Biological Chemistry 272 9043-9047.
36. Walenta JH, Didier AJ, Liu X & Kramer H 2001 The Golgi-associated hook3 protein is a member of a novel family of microtubule-binding proteins. Journal of Cell Biology 152 923-934.
37. Xing M 2005 BRAF mutation in thyroid cancer. Endocrine-Related Cancer 12 245-262.
38. Zhu Z, Gandhi M, Nikiforova MN, Fischer AH & Nikiforov YE 2003 Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. American Journal of Clinical Pathology 120 71-77.